Bank of New York Mellon’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,324
| Closed | -$33.3K | – | 4210 |
|
|
2025
Q1 | $33.3K | Sell |
27,324
-2,440
| -8% | -$2.98K | ﹤0.01% | 4053 |
|
|
2024
Q4 | $56.3K | Buy |
29,764
+9,211
| +45% | +$17.4K | ﹤0.01% | 4047 |
|
|
2024
Q3 | $110K | Buy |
20,553
+193
| +0.9% | +$1.03K | ﹤0.01% | 3990 |
|
|
2024
Q2 | $150K | Buy |
20,360
+377
| +2% | +$2.78K | ﹤0.01% | 3981 |
|
|
2024
Q1 | $239K | Sell |
19,983
-1,745
| -8% | -$20.8K | ﹤0.01% | 3871 |
|
|
2023
Q4 | $171K | Hold |
21,728
| – | – | ﹤0.01% | 3987 |
|
|
2023
Q3 | $96K | Sell |
21,728
-1,963
| -8% | -$8.68K | ﹤0.01% | 4080 |
|
|
2023
Q2 | $824K | Buy |
23,691
+2,612
| +12% | +$90.9K | ﹤0.01% | 3315 |
|
|
2023
Q1 | $460K | Buy |
21,079
+3,199
| +18% | +$69.7K | ﹤0.01% | 3531 |
|
|
2022
Q4 | $386K | Sell |
17,880
-15
| -0.1% | -$324 | ﹤0.01% | 3681 |
|
|
2022
Q3 | $437K | Buy |
17,895
+1,298
| +8% | +$31.7K | ﹤0.01% | 3640 |
|
|
2022
Q2 | $339K | Sell |
16,597
-24
| -0.1% | -$490 | ﹤0.01% | 3818 |
|
|
2022
Q1 | $592K | Buy |
16,621
+2,081
| +14% | +$74.1K | ﹤0.01% | 3611 |
|
|
2021
Q4 | $395K | Buy |
14,540
+246
| +2% | +$6.68K | ﹤0.01% | 3944 |
|
|
2021
Q3 | $621K | Buy |
14,294
+2,670
| +23% | +$116K | ﹤0.01% | 3673 |
|
|
2021
Q2 | $578K | Buy |
11,624
+6,865
| +144% | +$341K | ﹤0.01% | 3700 |
|
|
2021
Q1 | $214K | Sell |
4,759
-417
| -8% | -$18.8K | ﹤0.01% | 4028 |
|
|
2020
Q4 | $135K | Buy |
5,176
+2,633
| +104% | +$68.7K | ﹤0.01% | 4043 |
|
|
2020
Q3 | $37K | Hold |
2,543
| – | – | ﹤0.01% | 4048 |
|
|
2020
Q2 | $66K | Hold |
2,543
| – | – | ﹤0.01% | 3942 |
|
|
2020
Q1 | $31K | Buy |
+2,543
| New | +$31K | ﹤0.01% | 4014 |
|